Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations.
Intra-uterine growth restriction (IUGR) is defined by a restriction of fetal growth during gestation. It is a prevalent significant public health problem that jeopardizes neonatal health but also that can have deleterious consequences later in adult life. Cullins constitute a family of seven proteins involved in cell scaffold and in selective proteolysis via the ubiquitin-proteasome system. Most Cullins are critical for early embryonic development and mutations in some Cullin genes have been identified in human syndromes including growth retardation. Our work hypothesis is that Cullins, particularly CUL4B and CUL7, are involved in placental diseases and especially in IUGR. Thus, expression of Cullins and their cofactors was analyzed in normal and pathological placentas. We show that they present a constant significant over-expression in IUGR placentas, whose extent is dependent on the position of the interrogated fragment along the cDNAs, suggesting the existence of different isoforms of the genes. Particularly, the CUL7 gene is up-regulated up to 10 times in IUGR and 15 times in preeclampsia associated with IUGR. The expression of cofactors of Cullins participating to functional complexes has also been evaluated and showed a similar significant increase in IUGR. Promoters of Cullin genes appeared to be under the control of the SP1 transcription factor. Finally, methylation levels of the CUL7 promoter in placental tissues are modulated according to the pathological conditions, with a significant hypomethylation in IUGR. These results concur to pinpoint the Cullin family as a new set of markers of IUGR.
Gascoin-Lachambre
G
G
Département Génétique et Développement, Institut Cochin, INSERM u567, CNRS UMR 8104, Faculté de Médecine Université Paris Descartes, Paris, France.
Buffat
C
C
Rebourcet
R
R
Chelbi
S T
ST
Rigourd
V
V
Mondon
F
F
Mignot
T-M
TM
Legras
E
E
Simeoni
U
U
Vaiman
D
D
Barbaux
S
S
D015415:Biomarkers / Q000378:metabolism; D045744:Cell Line, Tumor; D044842:Cullin Proteins / Q000235:genetics / Q000378:metabolism*; D019175:DNA Methylation; D044127:Epigenesis, Genetic; D005260:Female; D005317:Fetal Growth Retardation / Q000378:metabolism* / Q000503:physiopathology; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D010920:Placenta / Q000378:metabolism*; D010922:Placenta Diseases / Q000378:metabolism / Q000503:physiopathology; D011225:Pre-Eclampsia / Q000378:metabolism; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000235:genetics / Q000378:metabolism; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D016329:Sp1 Transcription Factor / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D014652:Vascular Diseases / Q000150:complications / Q000378:metabolism
D015415:Biomarkers; C517832:CUL4B protein, human; C506299:CUL7 protein, human; D044842:Cullin Proteins; D011257:Pregnancy Proteins; D020033:Protein Isoforms; D012333:RNA, Messenger; D016329:Sp1 Transcription Factor